These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9727901)

  • 1. Plasma lipoprotein(a) levels are not influenced by glycemic control in type 1 diabetes.
    Pérez A; Carreras G; Caixàs A; Castellví A; Caballero A; Bonet R; Ordóñez-Llanos J; de Leiva A
    Diabetes Care; 1998 Sep; 21(9):1517-20. PubMed ID: 9727901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of change of lipoprotein(a) levels by the optimization of glycemic control with insulin therapy in NIDDM patients.
    Caixas A; Pérez A; Qrdóñez-Llanos J; Bonet R; Rigla M; Castellví A; Bayen L; de Leiva A
    Diabetes Care; 1997 Sep; 20(9):1459-61. PubMed ID: 9283797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum lipoprotein (a) in type 1 diabetic children and adolescents: relationships with HbA1c and subclinical complications.
    Willems D; Dorchy H; Dufrasne D
    Eur J Pediatr; 1996 Mar; 155(3):175-8. PubMed ID: 8929723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of lipoprotein(a), apolipoprotein B, and lipoprotein cholesterol distribution in IDDM. Results from follow-up in the Diabetes Control and Complications Trial.
    Purnell JQ; Marcovina SM; Hokanson JE; Kennedy H; Cleary PA; Steffes MW; Brunzell JD
    Diabetes; 1995 Oct; 44(10):1218-26. PubMed ID: 7556961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and phenotypic distribution of dyslipidemia in type 1 diabetes mellitus: effect of glycemic control.
    Pérez A; Wägner AM; Carreras G; Giménez G; Sánchez-Quesada JL; Rigla M; Gómez-Gerique JA; Pou JM; de Leiva A
    Arch Intern Med; 2000 Oct; 160(18):2756-62. PubMed ID: 11025785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of long-term glycaemic control on serum lipoprotein(a) levels in patients with Type 2 diabetes mellitus.
    Song KH; Ahn YB; Yoon KH; Cha BY; Lee KW; Son HY; Kang SK
    Diabet Med; 1999 Dec; 16(12):1036-9. PubMed ID: 10656233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of different insulin regimens in elderly patients with NIDDM.
    Wolffenbuttel BH; Sels JP; Rondas-Colbers GJ; Menheere PP; Nieuwenhuijzen Kruseman AC
    Diabetes Care; 1996 Dec; 19(12):1326-32. PubMed ID: 8941458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum lipoprotein(a) in patients with diabetes mellitus.
    Heller FR; Jamart J; Honore P; Derue G; Novik V; Galanti L; Parfonry A; Hondekijn JC; Buysschaert M
    Diabetes Care; 1993 May; 16(5):819-23. PubMed ID: 8495624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different change in lipoprotein(a) levels from lipid levels of other lipoproteins with improved glycemic control in patients with NIDDM.
    Kikuchi T; Onuma T; Shimura M; Tsutsui M; Boku A; Matsui J; Takebe K
    Diabetes Care; 1994 Sep; 17(9):1059-61. PubMed ID: 7988307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complementary insulin therapy improves blood glucose and serum lipid parameters in type 2 (non-insulin-dependent) diabetic patients. II. Effects on serum lipids, lipoproteins and apoproteins.
    Vaverková H; Chlup R; Ficker L; Novotny D; Bartek J
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():74-7. PubMed ID: 9288551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein (a) and other risk factors in children with insulin-dependent diabetes mellitus and children without diabetes.
    Martinez MT; Ramos O; Carretero N; Calvillán M; Gutierrez-López MD; Cuesta P; Serrano-Ríos M
    Diabete Metab; 1994; 20(5):454-7. PubMed ID: 7859892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum lipids and lipoprotein(a) concentrations in Chinese NIDDM patients. Relation to metabolic control.
    Chang CJ; Kao JT; Wu TJ; Lu FH; Tai TY
    Diabetes Care; 1995 Aug; 18(8):1191-4. PubMed ID: 7587858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved blood glucose control by insulin therapy in type 2 diabetic patients has no effect on lipoprotein(a) levels.
    Wolffenbuttel BH; Leurs PB; Sels JP; Rondas-Colbers GJ; Menheere PP; Nieuwenhuijzen Kruseman AC
    Diabet Med; 1993 Jun; 10(5):427-30. PubMed ID: 8334821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of HbA1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps.
    Melki V; Renard E; Lassmann-Vague V; Boivin S; Guerci B; Hanaire-Broutin H; Bringer J; Belicar P; Jeandidier N; Meyer L; Blin P; Augendre-Ferrante B; Tauber JP
    Diabetes Care; 1998 Jun; 21(6):977-82. PubMed ID: 9614617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous glucose monitoring in children with type 1 diabetes: before and after insulin pump therapy.
    Heptulla RA; Allen HF; Gross TM; Reiter EO
    Pediatr Diabetes; 2004 Mar; 5(1):10-5. PubMed ID: 15043684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of insulin lispro with regular human insulin for the treatment of type 1 diabetes in adolescents.
    Holcombe JH; Zalani S; Arora VK; Mast CJ;
    Clin Ther; 2002 Apr; 24(4):629-38. PubMed ID: 12017407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of lipoprotein(a) concentration with glycemic control in non-insulin-dependent diabetic subjects without diabetic complications.
    Nakata H; Horita K; Eto M
    Metabolism; 1993 Oct; 42(10):1323-6. PubMed ID: 8412745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of rosiglitazone on serum lipoprotein(a) levels in Korean patients with type 2 diabetes mellitus.
    Ko SH; Song KH; Ahn YB; Yoo SJ; Son HS; Yoon KH; Cha BY; Lee KW; Son HY; Kang SK
    Metabolism; 2003 Jun; 52(6):731-4. PubMed ID: 12800099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decrease of lipoprotein(a) with improved glycemic control in IDDM subjects.
    Haffner SM; Tuttle KR; Rainwater DL
    Diabetes Care; 1991 Apr; 14(4):302-7. PubMed ID: 1829405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential influence of LDL cholesterol and triglycerides on lipoprotein(a) concentrations in diabetic patients.
    Hernández C; Chacón P; García-Pascual L; Simó R
    Diabetes Care; 2001 Feb; 24(2):350-5. PubMed ID: 11213891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.